Loading clinical trials...
Loading clinical trials...
Effect and Safety of Limosilactobacillus Reuteri LM1063 Supplementation on the Improvement of Sleep Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Conditions
Interventions
Limosilactobacillus reuteri LM1063
Placebo
Locations
1
South Korea
P&K Skin Research Center
Seoul, Yeongdeungpo, South Korea
Start Date
July 14, 2025
Primary Completion Date
March 27, 2026
Completion Date
June 30, 2026
Last Updated
March 27, 2026
NCT05742776
NCT07168577
NCT07345260
NCT06700525
NCT07322731
NCT06359808
Lead Sponsor
Lactomason Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions